Welcome to AMIGOs

Australasian Merkel Cell Carcinoma Interest Group

“Enabling access to high quality care for all patients with Merkel Cell Carcinoma”

What is Merkel Cell Carcinoma?

Merkel Cell Carcinoma is a rare but highly aggressive neuroendocrine skin cancer.

Merkel Cell Carcinoma has the potential to be lethal and appropriate management should be sought immediately through a specialist centre.
Treatment often will involve several types of therapy such as surgery, radiation, and sometimes systemic medications. Multidisciplinary evaluation of patients with this cancer is critical to determine and carry out a proper treatment plan.

“Many patients and primary care doctors don’t understand the severity of a Merkel Cell Carcinoma diagnosis. Carers and families often don’t appreciate the seriousness of the condition. How could a skin cancer that you have never heard of, give you a deadly problem, unless it is malignant melanoma? Merkel Cell Carcinoma patients need quick referral to specialists at centres of excellence who understand this disease.”

Jonathan Pincus
Chair, Patient Advocacy Group

Jonathan Pincus


UPDATE - A snapshot of how our clinical trials are tracking, from the latest recruitment figures to sites activated.
#clinicaltrials #clinicaltrial #fightcancer #cancerresearch #melanoma


The I-MAT trial aims to improve outcomes for people like 86 year old Michael, who was recently diagnosed with the rare and aggressive #Merkelcell carcinoma. More info at https://t.co/iQMRTYYFNH #clinicaltrial #cancerresearch

A BIG step for improving regional access to life saving #ClinicalTrials with I-MAT opening our first #Teletrial site at @CairnsHHS! Thanks to Dr Madhavi Chilkuri Dr Megan Lyle & the @TownsvilleHHS team for this momentous opening #CancerResearch #RuralAustralia #RegionalAustralia

JOIN OUR BOARD - We're seeking 2 Board Directors to help us shape the strategy & vision of research to improve diagnosis and treatment of #melanoma and skin cancer https://t.co/cDXWq4AbZI #Recruitment #ClinicalTrials #CancerResearch #BoardOfDirectors

Load More...